BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 12027417)

  • 1. Targeting monocyte recruitment in CNS autoimmune disease.
    Izikson L; Klein RS; Luster AD; Weiner HL
    Clin Immunol; 2002 May; 103(2):125-31. PubMed ID: 12027417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemokine system in neuroinflammation: an update.
    Ransohoff RM
    J Infect Dis; 2002 Dec; 186 Suppl 2():S152-6. PubMed ID: 12424691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine receptor CXCR3: an unexpected enigma.
    Liu L; Callahan MK; Huang D; Ransohoff RM
    Curr Top Dev Biol; 2005; 68():149-81. PubMed ID: 16124999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system.
    Mildner A; Mack M; Schmidt H; Brück W; Djukic M; Zabel MD; Hille A; Priller J; Prinz M
    Brain; 2009 Sep; 132(Pt 9):2487-500. PubMed ID: 19531531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis.
    Karpus WJ; Ransohoff RM
    J Immunol; 1998 Sep; 161(6):2667-71. PubMed ID: 9743321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of CD8-positive macrophages infiltrating the central nervous system of rats with chronic autoimmune encephalomyelitis.
    Hiraki K; Park IK; Kohyama K; Matsumoto Y
    J Neurosci Res; 2009 Apr; 87(5):1175-84. PubMed ID: 18951531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of chemokine antagonists in EAE models.
    Proudfoot AE; de Souza AL; Muzio V
    J Neuroimmunol; 2008 Jul; 198(1-2):27-30. PubMed ID: 18550179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.
    Göser S; Ottl R; Brodner A; Dengler TJ; Torzewski J; Egashira K; Rose NR; Katus HA; Kaya Z
    Circulation; 2005 Nov; 112(22):3400-7. PubMed ID: 16316965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking.
    Pedersen LB; Nashold FE; Spach KM; Hayes CE
    J Neurosci Res; 2007 Aug; 85(11):2480-90. PubMed ID: 17600374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of experimental autoimmune uveitis: efficient recruitment of monocytes is independent of CCR2.
    Dagkalis A; Wallace C; Xu H; Liebau S; Manivannan A; Stone MA; Mack M; Liversidge J; Crane IJ
    Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4288-94. PubMed ID: 19357362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encephalitogenic lymphoblast recruitment to resting CNS microvasculature: a natural immunosurveillance mechanism?
    Alon R
    J Clin Invest; 2001 Aug; 108(4):517-9. PubMed ID: 11518723
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of chemokine receptors CCR7 and CCR8 in the CNS during ChREAE.
    Bielecki B; Mazurek A; Wolinski P; Glabinski A
    Scand J Immunol; 2007 Oct; 66(4):383-92. PubMed ID: 17850582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of chemokine and receptors in Lewis rats with experimental autoimmune anterior uveitis.
    Fang IM; Yang CH; Lin CP; Yang CM; Chen MS
    Exp Eye Res; 2004 Jun; 78(6):1043-55. PubMed ID: 15109911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression and function of chemokines involved in CNS inflammation.
    Ubogu EE; Cossoy MB; Ransohoff RM
    Trends Pharmacol Sci; 2006 Jan; 27(1):48-55. PubMed ID: 16310865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fc receptors and the common gamma-chain in experimental autoimmune encephalomyelitis.
    Szalai AJ; Barnum SR
    J Neurosci Res; 2004 Mar; 75(5):597-602. PubMed ID: 14991835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
    Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
    Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of methallothioneins in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Espejo C; Martínez-Cáceres EM
    Ann N Y Acad Sci; 2005 Jun; 1051():88-96. PubMed ID: 16126947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility to experimental allergic encephalomyelitis in animal models of autoimmunity.
    Lublin FD
    Curr Opin Neurol Neurosurg; 1992 Apr; 5(2):182-7. PubMed ID: 1377972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE).
    Mahad DJ; Ransohoff RM
    Semin Immunol; 2003 Feb; 15(1):23-32. PubMed ID: 12495638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis.
    El Behi M; Dubucquoi S; Lefranc D; Zéphir H; De Seze J; Vermersch P; Prin L
    Immunol Lett; 2005 Jan; 96(1):11-26. PubMed ID: 15585303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.